img

Global Cell and Gene Therapy Solutions Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cell and Gene Therapy Solutions Market Insights, Forecast to 2034

Cell & gene therapies are used to treat both rare and common diseases. While gene therapy involves the transfer of genetic material, usually within a virus for uptake into diseased cells, cell therapy involves the transfer of genetically altered cells into a patient.
Market Analysis and InsightsGlobal Cell and Gene Therapy Solutions Market
Global Cell and Gene Therapy Solutions market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Cell and Gene Therapy Solutions industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The field of cell and gene therapy is currently in a phase of robust growth, with an expanding market size. As scientific advancements continue, the application scope of cell and gene therapies is widening, encompassing the treatment of various diseases such as cancer, genetic disorders, and autoimmune conditions. Sales within this sector are on a consistent upward trajectory, reflecting significant commercial potential. While some remarkable successes have been achieved in the realm of cell and gene therapy, challenges concerning safety and regulatory compliance persist. Looking ahead, as research deepens, it is anticipated that the field will continue to make breakthroughs, ushering in more innovation and transformative changes within the medical domain.
Report Covers
This report presents an overview of global Cell and Gene Therapy Solutions market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Cell and Gene Therapy Solutions market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bluebird Bio
Sarepta Therapeutics
Solid Biosciences
Novartis
Biomarin Pharmaceutical
Uniqure
Spark Therapeutics
Alaunos Therapeutics
Homology Medicines
Biogen
Legend Biotech
CARsgen
Segment by Type
Stem Cell Therapy
Gene Therapy
Other

Segment by Application


Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Cell and Gene Therapy Solutions introduction, etc. Cell and Gene Therapy Solutions Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Cell and Gene Therapy Solutions
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Solutions Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Stem Cell Therapy
1.2.3 Gene Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Solutions Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Solutions Market Perspective (2018-2029)
2.2 Global Cell and Gene Therapy Solutions Growth Trends by Region
2.2.1 Cell and Gene Therapy Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell and Gene Therapy Solutions Historic Market Size by Region (2018-2024)
2.2.3 Cell and Gene Therapy Solutions Forecasted Market Size by Region (2024-2029)
2.3 Cell and Gene Therapy Solutions Market Dynamics
2.3.1 Cell and Gene Therapy Solutions Industry Trends
2.3.2 Cell and Gene Therapy Solutions Market Drivers
2.3.3 Cell and Gene Therapy Solutions Market Challenges
2.3.4 Cell and Gene Therapy Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cell and Gene Therapy Solutions by Players
3.1.1 Global Cell and Gene Therapy Solutions Revenue by Players (2018-2024)
3.1.2 Global Cell and Gene Therapy Solutions Revenue Market Share by Players (2018-2024)
3.2 Global Cell and Gene Therapy Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cell and Gene Therapy Solutions, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Cell and Gene Therapy Solutions Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Solutions Revenue in 2022
3.5 Global Key Players of Cell and Gene Therapy Solutions Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Solutions, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Solutions Breakdown Data by Type
4.1 Global Cell and Gene Therapy Solutions Historic Market Size by Type (2018-2024)
4.2 Global Cell and Gene Therapy Solutions Forecasted Market Size by Type (2024-2029)
5 Cell and Gene Therapy Solutions Breakdown Data by Application
5.1 Global Cell and Gene Therapy Solutions Historic Market Size by Application (2018-2024)
5.2 Global Cell and Gene Therapy Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell and Gene Therapy Solutions Market Size (2018-2029)
6.2 North America Cell and Gene Therapy Solutions Market Size by Type
6.2.1 North America Cell and Gene Therapy Solutions Market Size by Type (2018-2024)
6.2.2 North America Cell and Gene Therapy Solutions Market Size by Type (2024-2029)
6.2.3 North America Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
6.3 North America Cell and Gene Therapy Solutions Market Size by Application
6.3.1 North America Cell and Gene Therapy Solutions Market Size by Application (2018-2024)
6.3.2 North America Cell and Gene Therapy Solutions Market Size by Application (2024-2029)
6.3.3 North America Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
6.4 North America Cell and Gene Therapy Solutions Market Size by Country
6.4.1 North America Cell and Gene Therapy Solutions Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Cell and Gene Therapy Solutions Market Size by Country (2018-2024)
6.4.3 North America Cell and Gene Therapy Solutions Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Solutions Market Size (2018-2029)
7.2 Europe Cell and Gene Therapy Solutions Market Size by Type
7.2.1 Europe Cell and Gene Therapy Solutions Market Size by Type (2018-2024)
7.2.2 Europe Cell and Gene Therapy Solutions Market Size by Type (2024-2029)
7.2.3 Europe Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
7.3 Europe Cell and Gene Therapy Solutions Market Size by Application
7.3.1 Europe Cell and Gene Therapy Solutions Market Size by Application (2018-2024)
7.3.2 Europe Cell and Gene Therapy Solutions Market Size by Application (2024-2029)
7.3.3 Europe Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
7.4 Europe Cell and Gene Therapy Solutions Market Size by Country
7.4.1 Europe Cell and Gene Therapy Solutions Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Cell and Gene Therapy Solutions Market Size by Country (2018-2024)
7.4.3 Europe Cell and Gene Therapy Solutions Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cell and Gene Therapy Solutions Market Size (2018-2029)
8.2 China Cell and Gene Therapy Solutions Market Size by Type
8.2.1 China Cell and Gene Therapy Solutions Market Size by Type (2018-2024)
8.2.2 China Cell and Gene Therapy Solutions Market Size by Type (2024-2029)
8.2.3 China Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
8.3 China Cell and Gene Therapy Solutions Market Size by Application
8.3.1 China Cell and Gene Therapy Solutions Market Size by Application (2018-2024)
8.3.2 China Cell and Gene Therapy Solutions Market Size by Application (2024-2029)
8.3.3 China Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cell and Gene Therapy Solutions Market Size (2018-2029)
9.2 Asia Cell and Gene Therapy Solutions Market Size by Type
9.2.1 Asia Cell and Gene Therapy Solutions Market Size by Type (2018-2024)
9.2.2 Asia Cell and Gene Therapy Solutions Market Size by Type (2024-2029)
9.2.3 Asia Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
9.3 Asia Cell and Gene Therapy Solutions Market Size by Application
9.3.1 Asia Cell and Gene Therapy Solutions Market Size by Application (2018-2024)
9.3.2 Asia Cell and Gene Therapy Solutions Market Size by Application (2024-2029)
9.3.3 Asia Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
9.4 Asia Cell and Gene Therapy Solutions Market Size by Region
9.4.1 Asia Cell and Gene Therapy Solutions Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Cell and Gene Therapy Solutions Market Size by Region (2018-2024)
9.4.3 Asia Cell and Gene Therapy Solutions Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Cell and Gene Therapy Solutions Introduction
11.1.4 Bluebird Bio Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.1.5 Bluebird Bio Recent Developments
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Cell and Gene Therapy Solutions Introduction
11.2.4 Sarepta Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.2.5 Sarepta Therapeutics Recent Developments
11.3 Solid Biosciences
11.3.1 Solid Biosciences Company Details
11.3.2 Solid Biosciences Business Overview
11.3.3 Solid Biosciences Cell and Gene Therapy Solutions Introduction
11.3.4 Solid Biosciences Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.3.5 Solid Biosciences Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cell and Gene Therapy Solutions Introduction
11.4.4 Novartis Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.4.5 Novartis Recent Developments
11.5 Biomarin Pharmaceutical
11.5.1 Biomarin Pharmaceutical Company Details
11.5.2 Biomarin Pharmaceutical Business Overview
11.5.3 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Introduction
11.5.4 Biomarin Pharmaceutical Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.5.5 Biomarin Pharmaceutical Recent Developments
11.6 Uniqure
11.6.1 Uniqure Company Details
11.6.2 Uniqure Business Overview
11.6.3 Uniqure Cell and Gene Therapy Solutions Introduction
11.6.4 Uniqure Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.6.5 Uniqure Recent Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Cell and Gene Therapy Solutions Introduction
11.7.4 Spark Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.7.5 Spark Therapeutics Recent Developments
11.8 Alaunos Therapeutics
11.8.1 Alaunos Therapeutics Company Details
11.8.2 Alaunos Therapeutics Business Overview
11.8.3 Alaunos Therapeutics Cell and Gene Therapy Solutions Introduction
11.8.4 Alaunos Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.8.5 Alaunos Therapeutics Recent Developments
11.9 Homology Medicines
11.9.1 Homology Medicines Company Details
11.9.2 Homology Medicines Business Overview
11.9.3 Homology Medicines Cell and Gene Therapy Solutions Introduction
11.9.4 Homology Medicines Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.9.5 Homology Medicines Recent Developments
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Cell and Gene Therapy Solutions Introduction
11.10.4 Biogen Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.10.5 Biogen Recent Developments
11.11 Legend Biotech
11.11.1 Legend Biotech Company Details
11.11.2 Legend Biotech Business Overview
11.11.3 Legend Biotech Cell and Gene Therapy Solutions Introduction
11.11.4 Legend Biotech Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.11.5 Legend Biotech Recent Developments
11.12 CARsgen
11.12.1 CARsgen Company Details
11.12.2 CARsgen Business Overview
11.12.3 CARsgen Cell and Gene Therapy Solutions Introduction
11.12.4 CARsgen Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.12.5 CARsgen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cell and Gene Therapy Solutions Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Stem Cell Therapy
Table 3. Key Players of Gene Therapy
Table 4. Key Players of Other
Table 5. Global Cell and Gene Therapy Solutions Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Cell and Gene Therapy Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cell and Gene Therapy Solutions Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Cell and Gene Therapy Solutions Market Share by Region (2018-2024)
Table 9. Global Cell and Gene Therapy Solutions Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Cell and Gene Therapy Solutions Market Share by Region (2024-2029)
Table 11. Cell and Gene Therapy Solutions Market Trends
Table 12. Cell and Gene Therapy Solutions Market Drivers
Table 13. Cell and Gene Therapy Solutions Market Challenges
Table 14. Cell and Gene Therapy Solutions Market Restraints
Table 15. Global Cell and Gene Therapy Solutions Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Cell and Gene Therapy Solutions Revenue Share by Players (2018-2024)
Table 17. Global Top Cell and Gene Therapy Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Solutions as of 2022)
Table 18. Global Cell and Gene Therapy Solutions Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Solutions Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Cell and Gene Therapy Solutions, Headquarters and Area Served
Table 21. Global Key Players of Cell and Gene Therapy Solutions, Product and Application
Table 22. Global Key Players of Cell and Gene Therapy Solutions, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell and Gene Therapy Solutions Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Cell and Gene Therapy Solutions Revenue Market Share by Type (2018-2024)
Table 26. Global Cell and Gene Therapy Solutions Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Cell and Gene Therapy Solutions Revenue Market Share by Type (2024-2029)
Table 28. Global Cell and Gene Therapy Solutions Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Cell and Gene Therapy Solutions Revenue Share by Application (2018-2024)
Table 30. Global Cell and Gene Therapy Solutions Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Cell and Gene Therapy Solutions Revenue Share by Application (2024-2029)
Table 32. North America Cell and Gene Therapy Solutions Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Cell and Gene Therapy Solutions Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Cell and Gene Therapy Solutions Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Cell and Gene Therapy Solutions Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Cell and Gene Therapy Solutions Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Cell and Gene Therapy Solutions Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Cell and Gene Therapy Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Cell and Gene Therapy Solutions Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Cell and Gene Therapy Solutions Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Cell and Gene Therapy Solutions Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Cell and Gene Therapy Solutions Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Cell and Gene Therapy Solutions Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Cell and Gene Therapy Solutions Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Cell and Gene Therapy Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Cell and Gene Therapy Solutions Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Cell and Gene Therapy Solutions Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Cell and Gene Therapy Solutions Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Cell and Gene Therapy Solutions Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Cell and Gene Therapy Solutions Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Cell and Gene Therapy Solutions Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Cell and Gene Therapy Solutions Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Cell and Gene Therapy Solutions Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Cell and Gene Therapy Solutions Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Cell and Gene Therapy Solutions Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Cell and Gene Therapy Solutions Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 64. Bluebird Bio Company Details
Table 65. Bluebird Bio Business Overview
Table 66. Bluebird Bio Cell and Gene Therapy Solutions Product
Table 67. Bluebird Bio Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 68. Bluebird Bio Recent Developments
Table 69. Sarepta Therapeutics Company Details
Table 70. Sarepta Therapeutics Business Overview
Table 71. Sarepta Therapeutics Cell and Gene Therapy Solutions Product
Table 72. Sarepta Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 73. Sarepta Therapeutics Recent Developments
Table 74. Solid Biosciences Company Details
Table 75. Solid Biosciences Business Overview
Table 76. Solid Biosciences Cell and Gene Therapy Solutions Product
Table 77. Solid Biosciences Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 78. Solid Biosciences Recent Developments
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Cell and Gene Therapy Solutions Product
Table 82. Novartis Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 83. Novartis Recent Developments
Table 84. Biomarin Pharmaceutical Company Details
Table 85. Biomarin Pharmaceutical Business Overview
Table 86. Biomarin Pharmaceutical Cell and Gene Therapy Solutions Product
Table 87. Biomarin Pharmaceutical Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 88. Biomarin Pharmaceutical Recent Developments
Table 89. Uniqure Company Details
Table 90. Uniqure Business Overview
Table 91. Uniqure Cell and Gene Therapy Solutions Product
Table 92. Uniqure Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 93. Uniqure Recent Developments
Table 94. Spark Therapeutics Company Details
Table 95. Spark Therapeutics Business Overview
Table 96. Spark Therapeutics Cell and Gene Therapy Solutions Product
Table 97. Spark Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 98. Spark Therapeutics Recent Developments
Table 99. Alaunos Therapeutics Company Details
Table 100. Alaunos Therapeutics Business Overview
Table 101. Alaunos Therapeutics Cell and Gene Therapy Solutions Product
Table 102. Alaunos Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 103. Alaunos Therapeutics Recent Developments
Table 104. Homology Medicines Company Details
Table 105. Homology Medicines Business Overview
Table 106. Homology Medicines Cell and Gene Therapy Solutions Product
Table 107. Homology Medicines Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 108. Homology Medicines Recent Developments
Table 109. Biogen Company Details
Table 110. Biogen Business Overview
Table 111. Biogen Cell and Gene Therapy Solutions Product
Table 112. Biogen Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 113. Biogen Recent Developments
Table 114. Legend Biotech Company Details
Table 115. Legend Biotech Business Overview
Table 116. Legend Biotech Cell and Gene Therapy Solutions Product
Table 117. Legend Biotech Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 118. Legend Biotech Recent Developments
Table 119. CARsgen Company Details
Table 120. CARsgen Business Overview
Table 121. CARsgen Cell and Gene Therapy Solutions Product
Table 122. CARsgen Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 123. CARsgen Recent Developments
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Solutions Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Cell and Gene Therapy Solutions Market Share by Type: 2022 VS 2029
Figure 3. Stem Cell Therapy Features
Figure 4. Gene Therapy Features
Figure 5. Other Features
Figure 6. Global Cell and Gene Therapy Solutions Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Cell and Gene Therapy Solutions Market Share by Application: 2022 VS 2029
Figure 8. Neurological Diseases Case Studies
Figure 9. Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Cell and Gene Therapy Solutions Report Years Considered
Figure 12. Global Cell and Gene Therapy Solutions Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cell and Gene Therapy Solutions Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cell and Gene Therapy Solutions Market Share by Region: 2022 VS 2029
Figure 15. Global Cell and Gene Therapy Solutions Market Share by Players in 2022
Figure 16. Global Top Cell and Gene Therapy Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Solutions as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Solutions Revenue in 2022
Figure 18. North America Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
Figure 20. North America Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
Figure 21. North America Cell and Gene Therapy Solutions Market Share by Country (2018-2029)
Figure 22. United States Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy Solutions Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
Figure 26. Europe Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
Figure 27. Europe Cell and Gene Therapy Solutions Market Share by Country (2018-2029)
Figure 28. Germany Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Cell and Gene Therapy Solutions Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
Figure 36. China Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
Figure 37. Asia Cell and Gene Therapy Solutions Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
Figure 39. Asia Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
Figure 40. Asia Cell and Gene Therapy Solutions Market Share by Region (2018-2029)
Figure 41. Japan Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Cell and Gene Therapy Solutions Market Share by Country (2018-2029)
Figure 51. Brazil Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Bluebird Bio Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 58. Sarepta Therapeutics Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 59. Solid Biosciences Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 60. Novartis Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 61. Biomarin Pharmaceutical Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 62. Uniqure Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 63. Spark Therapeutics Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 64. Alaunos Therapeutics Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 65. Homology Medicines Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 66. Biogen Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 67. Legend Biotech Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 68. CARsgen Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed